Candidate early detection protein biomarkers for ER+/PR+ invasive ductal breast carcinoma identified using pre-clinical plasma from the WHI observational study

Breast Cancer Research and Treatment
Matthew F BuasChristopher I Li

Abstract

Estrogen receptor (ER)-positive/progesterone receptor (PR)-positive invasive ductal carcinoma accounts for ~45 % of invasive breast cancer (BC) diagnoses in the U.S. Despite reductions in BC mortality attributable to mammography screening and adjuvant hormonal therapy, an important challenge remains the development of clinically useful blood-based biomarkers for risk assessment and early detection. The objective of this study was to identify novel protein markers for ER+/PR+ ductal BC. A nested case-control study was conducted within the Women's Health Initiative observational study. Pre-clinical plasma specimens, collected up to 12.5 months before diagnosis from 121 cases and 121 matched controls, were equally divided into training and testing sets and interrogated using a customized antibody array targeting >2000 proteins. Statistically significant differences (P < 0.05) in matched case versus control signals were observed for 39 candidates in both training and testing sets, and four markers (CSF2, RYBP, TFRC, ITGB4) remained significant after Bonferroni correction (P < 2.03 × 10(-5)). A multivariate modeling procedure based on elastic net regression with Monte Carlo cross-validation achieved an estimated AUC of 0.75 (SD 0.06...Continue Reading

References

Jan 1, 1988·Proceedings of the National Academy of Sciences of the United States of America·Y BeguinC A Finch
Jun 1, 1995·The Journal of Family Practice·D C Slawson, M L Coates
Jan 11, 1995·JAMA : the Journal of the American Medical Association·K KerlikowskeV L Ernster
Sep 3, 2002·Annals of Internal Medicine·Linda L HumphreySteven H Woolf
Oct 25, 2003·Annals of Epidemiology·Jennifer HaysJacques E Rossouw
Nov 5, 2003·Methods : a Companion to Methods in Enzymology·Gordon K Smyth, Terry Speed
May 28, 2005·Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc·Leslie K DiazMichael Z Gilcrease
Aug 13, 2005·Bioinformatics·Tobias SingThomas Lengauer
Dec 3, 2005·Cancer Research·Elizabeth A LipscombArthur M Mercurio
Feb 27, 2007·Breast Cancer Research : BCR·Giulia BonRita Falcioni
Aug 28, 2007·Bioinformatics·Matthew E RitchieGordon K Smyth
Feb 19, 2008·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Shaolei LuArthur M Mercurio
Feb 23, 2008·Journal of Proteome Research·Shui-Tein ChenChun-Ming Huang
May 7, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Bernhard C PestalozziUNKNOWN International Breast Cancer Study Group
Dec 25, 2008·Methods in Molecular Biology·Mai Brooks
Feb 25, 2009·Breast Cancer Research and Treatment·Hany Onsy HabashyJulia M W Gee
Dec 1, 2007·Molecular Oncology·Christian M LochPaul D Lampe
Nov 19, 2009·Annals of Internal Medicine·UNKNOWN US Preventive Services Task Force
Dec 24, 2009·Nature Reviews. Cancer·Jay S Desgrosellier, David A Cheresh
May 15, 2010·Molecular & Cellular Proteomics : MCP·Arturo B RamirezPaul D Lampe
Oct 28, 2010·Journal of Proteome Research·Karen S AndersonJoshua Labaer
Dec 31, 2010·Journal of the National Cancer Institute·Xiaohong R YangMontserrat Garcia-Closas
Jul 2, 2011·Nature·UNKNOWN Cancer Genome Atlas Research Network
Aug 31, 2011·Cancer Research·Lance D MillerFrank M Torti
Dec 20, 2011·Cancer Treatment Reviews·Pilar ErolesAna Lluch
Aug 29, 2012·International Journal of Cancer. Journal International Du Cancer·Katarina CukBarbara Burwinkel
Sep 25, 2012·Nature·UNKNOWN Cancer Genome Atlas Network
Sep 24, 2013·Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology·Pauline Zaenker, Melanie R Ziman
Sep 26, 2013·Proceedings of the National Academy of Sciences of the United States of America·Johannes C FischerNikolas H Stoecklein
Oct 12, 2013·CA: a Cancer Journal for Clinicians·Carol DeSantisAhmedin Jemal
Nov 1, 2013·Cold Spring Harbor Protocols·Samir M Hanash, Ayumu Taguchi
Apr 3, 2014·JAMA : the Journal of the American Medical Association·Lydia E Pace, Nancy L Keating

❮ Previous
Next ❯

Citations

Dec 15, 2015·Expert Review of Proteomics·Radwa EwaishaKaren S Anderson
Oct 23, 2016·Journal of Proteome Research·Carly B GarrisonPaul D Lampe
Jan 18, 2019·Cancer Gene Therapy·Xiaofeng XuHuaijun Zhou
Nov 16, 2019·Gastroenterology·Andreana N HolowatyjUNKNOWN ColoCare Study

❮ Previous
Next ❯

Related Concepts

Related Feeds

Carcinoma, Ductal

Ductal carcinoma is a malignant neoplasm involving the ductal systems of any of a number of organs, such as the mammary glands, pancreas, prostate or lacrimal gland. Discover the latest research on ductal carcinoma here.

Breast Invasive Carcinoma (Keystone)

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.

Breast Cancer Triple-N

Breast cancer cells have receptors for estrogen, progesterone, HER2 receptors (also called ERBB2). Triple-negative breast cancers do not have any of these receptors. Here are the latest discoveries pertaining to triple-negative breast cancers.

Breast Cancer: Chemo-Resistance

Some cancers are difficult to treat and aggressive including the "triple-negative" breast cancer. This type of cancer is chemoresistant even before chemotherapy begins. Here are the latest discoveries chemo-resistance in breast cancer.

Breast Invasive Carcinoma

Invasive breast cancers indicate a spread into breast tissues and lymph nodes. Here are the latest discoveries pertaining to breast invasive carcinomas.